Golden, Colo. — January 7, 2016 — Needle-free flu shots using the PharmaJet Injection System were offered as an option at multiple corporate flu clinics this season including Ernst & Young (Phoenix, AZ), Jones Lang LaSalle (Denver, CO), and Provant (East Greenwich, RI).
Following the injection, participants were asked to complete a survey about their experience. Of those surveyed, 100 percent were satisfied and 93 percent said they would choose a needle-free flu shot again next year.
“We used the PharmaJet system in our own corporate flu clinic, as well as with one of our customers this year. We found that it was readily embraced by our employees, providers, and our customer and their clinic participants,” said Barbara Haydon, chief administration officer and senior vice president, Clinical Services at Provant.
“More than 20 percent of flu shots1 are now administered in a workplace setting which represents over 30 million shots annually. Corporate flu clinics are an important part of our commercial rollout for the PharmaJet Needle-free Injection System. Participants love the choice of a needle-free flu injection. Immunizers really like the technology because they can work fast and not worry about needles2,” said Ron Lowy, chairman and CEO of PharmaJet, Inc.
Because the PharmaJet Needle-free Injection System does not use any needles, it eliminates the possibility of needlestick injuries and provides individuals an alternative to receiving a flu vaccination in a way that reduces anxiety associated with needles. Additionally, the auto-disabling syringe precludes any possibility of syringe reuse. For more information on PharmaJet’s Needle-free Injector, please visit www.pharmajet.com.
- Health Industry Distributors Association (HIDA), 2014 Flu Market Brief, p.8
- Refer to Instructions for Use and the individual device & drug/biologic labeling for prescribing information to ensure safe injections and to review
Based in Golden, Colorado, PharmaJet’s mission is worldwide acceptance of PharmaJet needle-free devices as a standard of care in the vaccine delivery market. PharmaJet’s innovative Stratis® Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis® Needle-free Injector was cleared for delivery of an influenza vaccine to deliver needle-free flu shots. The PharmaJet Needle-free Injector is easy-to-use and eliminates needlestick injuries, needle reuse and cross contamination, and helps reduce sharps waste disposal. For more information, visit www.pharmajet.com.
Founded in 2001, Provant’s vision is to change the well-being of America, one person at a time. With its network of 13,000+ employees nationwide, Provant provides comprehensive workplace well-being solutions for organizations across all industries. Provant’s customized well-being programs are designed to increase human potential while aligning with individuals’ and organizations’ goals to change the pattern of healthcare utilization and cost trends. Provant’s programs are personalized to fit an individual’s well-being risks, while accounting for readiness and willingness to change. Provant currently provides the opportunity for better health to more than six million members.